The gastric emptying effect is largest in the first 4 to 8 weeks of GLP-1 therapy as plasma concentrations rise to steady state
However, long-term studies have established that Semaglutide is generally safe, with many of the side effects improving as treatment continues
None of the HBOT treated animals had retinal ganglion cell loss after rAION induction
In todays regulatory environment, robust ADA data is a key enabler for timely and successful submissions
Cost and insurance coverage are the biggest levers to GLP-1 adoption in Canada* Among Canadians with past/current/prospective GLP-1 interest (including alternative users), over half say that insurance coverage or a lower-cost generic would increase their likelihood of using a prescription GLP-1
Additionally, even with insurance coverage, drugs may still come at a premium cost meanwhile Strut keeps prices at a fixed rate due to its online model